---  
layout: startup_page  
title: "Metsera"  
id: "metsera.com"  
permalink: "/metserametsera.com11132024/"  
website: "https://metsera.com"  
funding_round: "Series B"  
funding_amount: "$215M"  
investors: "Wellington Management, Venrock, Fidelity Management & Research Company, Janus Henderson Investors, T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., Viking Global Investors, Deep Track Capital, RA Capital Management, ARCH Venture Partners, Alpha Wave Ventures, GV, SoftBank Vision Fund 2, Newpath Partners, SymBiosis"  
about: "Metsera is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and metabolic diseases. They are advancing a portfolio of oral and injectable therapies using proprietary peptide engineering platforms like HALO™ and MOMENTUM™. Their unique value proposition lies in their ultra-long-acting peptides and innovative oral delivery systems."  
markets: "Biotechnology, Pharmaceuticals, Obesity Treatment, Metabolic Disease Treatment"  
hq: "New York City, New York, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/metsera/"  
twitter: "https://x.com/MetseraInc"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/metsera"  
pitchbook: "https://pitchbook.com/profiles/company/593353-63"  

date_display: "13-Nov-2024"  
date: "2024-11-13"

# SEO Optimization  
meta_title: "Metsera - Series B Funding ($215M)"  
meta_description: "Metsera, Metsera is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and metabolic diseases. They are adv..."  
meta_keywords: "Metsera, Biotechnology, Pharmaceuticals, Obesity Treatment, Metabolic Disease Treatment, Series B funding"  
canonical_url: "https://startup.projectstartups.com/metserametsera.com11132024/"  
---